PL3556357T3 - Kompozycje pirydostygminy o przedłużonym uwalnianiu - Google Patents
Kompozycje pirydostygminy o przedłużonym uwalnianiuInfo
- Publication number
- PL3556357T3 PL3556357T3 PL18386007.1T PL18386007T PL3556357T3 PL 3556357 T3 PL3556357 T3 PL 3556357T3 PL 18386007 T PL18386007 T PL 18386007T PL 3556357 T3 PL3556357 T3 PL 3556357T3
- Authority
- PL
- Poland
- Prior art keywords
- sustained release
- pyridostigmine compositions
- release pyridostigmine
- compositions
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18386007.1A EP3556357B1 (en) | 2018-04-16 | 2018-04-16 | Sustained release pyridostigmine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3556357T3 true PL3556357T3 (pl) | 2023-12-04 |
Family
ID=62091819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18386007.1T PL3556357T3 (pl) | 2018-04-16 | 2018-04-16 | Kompozycje pirydostygminy o przedłużonym uwalnianiu |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12527777B2 (pl) |
| EP (1) | EP3556357B1 (pl) |
| JP (1) | JP7313426B2 (pl) |
| KR (1) | KR102858811B1 (pl) |
| AU (1) | AU2019254487B2 (pl) |
| CA (1) | CA3096151A1 (pl) |
| ES (1) | ES2954286T3 (pl) |
| HR (1) | HRP20230971T1 (pl) |
| HU (1) | HUE062809T2 (pl) |
| MD (1) | MD3556357T2 (pl) |
| PL (1) | PL3556357T3 (pl) |
| RS (1) | RS64537B1 (pl) |
| SM (1) | SMT202300264T1 (pl) |
| WO (1) | WO2019201909A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3556357T3 (pl) | 2018-04-16 | 2023-12-04 | Vianex S.A. | Kompozycje pirydostygminy o przedłużonym uwalnianiu |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10029201A1 (de) * | 2000-06-19 | 2001-12-20 | Basf Ag | Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung |
| TWI454288B (zh) * | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | 藥物劑型 |
| CA2947528C (en) | 2014-05-01 | 2023-09-05 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
| PL3556357T3 (pl) | 2018-04-16 | 2023-12-04 | Vianex S.A. | Kompozycje pirydostygminy o przedłużonym uwalnianiu |
-
2018
- 2018-04-16 PL PL18386007.1T patent/PL3556357T3/pl unknown
- 2018-04-16 RS RS20230681A patent/RS64537B1/sr unknown
- 2018-04-16 HU HUE18386007A patent/HUE062809T2/hu unknown
- 2018-04-16 SM SM20230264T patent/SMT202300264T1/it unknown
- 2018-04-16 EP EP18386007.1A patent/EP3556357B1/en active Active
- 2018-04-16 ES ES18386007T patent/ES2954286T3/es active Active
- 2018-04-16 MD MDE20200576T patent/MD3556357T2/ro unknown
- 2018-04-16 HR HRP20230971TT patent/HRP20230971T1/hr unknown
-
2019
- 2019-04-16 CA CA3096151A patent/CA3096151A1/en active Pending
- 2019-04-16 WO PCT/EP2019/059789 patent/WO2019201909A1/en not_active Ceased
- 2019-04-16 KR KR1020207031329A patent/KR102858811B1/ko active Active
- 2019-04-16 AU AU2019254487A patent/AU2019254487B2/en active Active
- 2019-04-16 JP JP2021506046A patent/JP7313426B2/ja active Active
- 2019-04-16 US US17/047,800 patent/US12527777B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2954286T3 (es) | 2023-11-21 |
| EP3556357A1 (en) | 2019-10-23 |
| US20210128539A1 (en) | 2021-05-06 |
| SMT202300264T1 (it) | 2023-11-13 |
| JP2021522319A (ja) | 2021-08-30 |
| HRP20230971T1 (hr) | 2023-12-08 |
| HUE062809T2 (hu) | 2023-12-28 |
| AU2019254487A1 (en) | 2020-11-19 |
| AU2019254487B2 (en) | 2024-07-11 |
| EP3556357B1 (en) | 2023-06-07 |
| US12527777B2 (en) | 2026-01-20 |
| CA3096151A1 (en) | 2019-10-24 |
| JP7313426B2 (ja) | 2023-07-24 |
| WO2019201909A1 (en) | 2019-10-24 |
| KR102858811B1 (ko) | 2025-09-12 |
| EP3556357C0 (en) | 2023-06-07 |
| MD3556357T2 (ro) | 2023-11-30 |
| KR20200143695A (ko) | 2020-12-24 |
| RS64537B1 (sr) | 2023-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3665237T3 (en) | Compositions | |
| GB2586745B (en) | Compositions | |
| GB201811312D0 (en) | Compositions | |
| SG11202104306XA (en) | Compositions | |
| GB201916960D0 (en) | Compositions | |
| DK3924442T3 (en) | Compositions | |
| IL289125A (en) | the vehicles | |
| IL289557A (en) | Sustained release formulations of endoxifen | |
| SG11202009259VA (en) | Compositions | |
| GB201908396D0 (en) | Compositions | |
| GB201719480D0 (en) | Compositions | |
| GB201707909D0 (en) | Compositions | |
| ZA202101464B (en) | Mousse composition | |
| GB201803923D0 (en) | Compositions | |
| PL3609464T3 (pl) | Kompozycje na bazie ksantohumolu | |
| GB201707454D0 (en) | Compositions | |
| IL287762A (en) | Controlled-release lipid preparations | |
| GB201919234D0 (en) | Compositions | |
| GB2570649B (en) | Compositions | |
| GB201805676D0 (en) | Compositions | |
| SMT202300264T1 (it) | Composizioni di piridostigmina a rilascio prolungato | |
| GB201717712D0 (en) | Compositions | |
| GB201703136D0 (en) | Compositions | |
| ZA202005658B (en) | Compositions | |
| GB201820233D0 (en) | Compositions |